Latest news about Invicta Diagnostic
Invicta Diagnostic
59.95
-1.05(-1.72%)
Company Performance:
View Company Insights1D-1.72%
1M-33.61%
6M-33.39%
1Y-38.00%
5Y-38.00%
More news about Invicta Diagnostic
20May 26
Invicta completes 47% stake sale in Porteus Medical
Invicta Diagnostic Limited completed the sale of its 47% stake in Porteus Medical LLP on May 16, 2026, for a consideration of ₹47000. The subsidiary had a nil turnover in FY 2024-25 and a net worth of Rs. 1.25 Lakhs. The transaction does not require compliance with regulation 37A of the LODR Regulations.
14May 26
Invicta Diagnostic Appoints M/s. Shrenik Nagaonkar & Associates as Secretarial Auditor for Five-Year Term
Invicta Diagnostic Limited's Board of Directors appointed M/s. Shrenik Nagaonkar & Associates, Company Secretaries, as Secretarial Auditor for a five-year term from FY 2025-26 to FY 2029-30, at its meeting held on May 13, 2026. The appointment was made in compliance with the Companies Act, 2013 and SEBI (LODR) Regulations, 2015, and is subject to shareholder approval at the ensuing Annual General Meeting. Mr. Shrenik Nagaonkar, the firm's proprietor, holds over 19 years of experience in corporate governance, corporate laws, security laws, and capital markets, and is a fellow member of the Institute of Company Secretaries of India.
09May 26
Invicta Diagnostic Limited Completes 51% Stake Acquisition in Vinchurkar Diagnostics Private Limited
Invicta Diagnostic Limited completed the acquisition of a 51% stake in Vinchurkar Diagnostics Private Limited on May 8, 2026, with shares credited to its demat account. The transaction was approved across Board Meetings held on January 5, March 25, and April 11, 2026, and disclosed under Regulation 30 of the SEBI (LODR) Regulations, 2015. All required regulatory details had been previously submitted to the National Stock Exchange of India Limited. The disclosure was authorised by Chairman and Non-Executive Director Sanket Vinod Jain from Mumbai.
Industry Peers
Dr. Lal Path Labs
Vijaya Diagnostic Centre
Metropolis Healthcare
Thyrocare Technologies
Nephrocare Health Services
Krsnaa Diagnostics
Suraksha Diagnostic
One Global Service Provider
3B BlackBio DX
Health X Platform
1,601.50
(+0.50%)
1,287.20
(+0.63%)
530.70
(+2.03%)
528.90
(+1.83%)
748.15
(-0.42%)
534.30
(+0.23%)
268.05
(0.0%)
633.90
(+4.93%)
1,245.40
(-0.69%)
280.90
(+0.90%)
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
